Dogwood Therapeutics, Inc. (DWTX)
1.69
-0.03
(-1.74%)
USD |
NASDAQ |
Sep 18, 16:00
1.70
+0.01
(+0.59%)
After-Hours: 20:00
Dogwood Therapeutics Total Liabilities (Quarterly) : 12.13M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 12.13M |
| March 31, 2026 | 14.58M |
| December 31, 2025 | 15.76M |
| September 30, 2025 | 14.61M |
| June 30, 2025 | 14.15M |
| March 31, 2025 | 89.90M |
| December 31, 2024 | 111.34M |
| September 30, 2024 | 1.334M |
| June 30, 2024 | 0.5001M |
| March 31, 2024 | 0.5701M |
| December 31, 2023 | 0.3585M |
| September 30, 2023 | 0.4871M |
| June 30, 2023 | 0.52M |
| Date | Value |
|---|---|
| March 31, 2023 | 0.5493M |
| December 31, 2022 | 1.043M |
| September 30, 2022 | 1.633M |
| June 30, 2022 | 1.898M |
| March 31, 2022 | 1.877M |
| December 31, 2021 | 1.276M |
| September 30, 2021 | 1.227M |
| June 30, 2021 | 0.9063M |
| March 31, 2021 | 1.167M |
| December 31, 2020 | 1.532M |
| September 30, 2020 | 5.935M |
| June 30, 2020 | 7.336M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 80.50M |
| Shareholders Equity (Quarterly) | 68.37M |
| Debt to Equity Ratio | 0.0019 |
| Current Ratio | 3.894 |
| Net Debt Paydown Yield | 27.97% |